| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Nishizawa Y and Shoji T | Does paricalcitol reduce proteinuria in patients with chronic kidney disease? | 2006 | Nat Clin Pract Nephrol | pmid:16932459 |
| Daphnis E et al. | Parathyromatosis and the challenge of treatment. | 2006 | Am. J. Kidney Dis. | pmid:16931226 |
| Seeherunvong W et al. | Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients. | 2006 | Pediatr. Nephrol. | pmid:16900383 |
| Wu-Wong JR et al. | Vitamin D receptor (VDR) localization in human promyelocytic leukemia cells. | 2006 | Leuk. Lymphoma | pmid:16690532 |
| Drüeke TB and Landais P | Paricalcitol for treatment of secondary hyperparathyroidism in CKD patients. | 2006 | Am. J. Kidney Dis. | pmid:16731305 |
| Chertow GM et al. | Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate. | 2006 | Clin J Am Soc Nephrol | pmid:17699221 |
| Cheng S and Coyne D | Paricalcitol capsules for the control of secondary hyperparathyroidism in chronic kidney disease. | 2006 | Expert Opin Pharmacother | pmid:16553577 |
| Abboud H et al. | A comparison of dosing regimens of paricalcitol capsule for the treatment of secondary hyperparathyroidism in CKD stages 3 and 4. | 2006 | Am. J. Nephrol. | pmid:16543714 |
| Mitsopoulos E et al. | Initial dosing of paricalcitol based on PTH levels in hemodialysis patients with secondary hyperparathyroidism. | 2006 | Am. J. Kidney Dis. | pmid:16797393 |
| Zierold C et al. | 19nor-1,25-dihydroxyvitamin D2 specifically induces CYP3A9 in rat intestine more strongly than 1,25-dihydroxyvitamin D3 in vivo and in vitro. | 2006 | Mol. Pharmacol. | pmid:16484501 |
Paricalcitol
Paricalcitol is a lipid of Sterol Lipids (ST) class. Paricalcitol is associated with abnormalities such as Vitamin D Deficiency. The involved functions are known as Hypertrophy, Left Ventricular. Paricalcitol often locates in Blood.
Cross Reference
Introduction
To understand associated biological information of Paricalcitol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Paricalcitol?
Paricalcitol is suspected in Vitamin D Deficiency and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with Paricalcitol
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Paricalcitol?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Paricalcitol?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.
What genes are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.